Skip to main content
Florian Schmidt Lea Jenster
© David Fußhöller / UKB

News categories: Publication

P38 as signaling hub for NLRP1 activation in the skin

Ribotoxic stress response to UV-radiation and microbial molecules activate p38, inducing human NLRP1 inflammasome assembly in keratinocytes

Inflammasomes integrate different cues of infection or cellular damage to trigger an inflammatory response. The Nucleotide-binding domain and leucine-rich repeat containing protein 1 (NLRP1) expressed in Keratinocytes coordinates inflammation in the skin. A recent study by ImmunoSensation2 scientists the University of Bonn in cooperation with colleagues at the University of Melbourne and the Boston Children’s Hospital has now identified p38 as the key molecule integrating various stress signals and inducing NLRP1 inflammasome assembly in human keratinocytes. The results have been published in the Journal of Experimental Medicine.

As the largest organ of the human body, the skin provides a major barrier to environmental stimuli and pathogens. Painful inflammation can be mounted if this barrier is compromised – as anyone who has ever had a sunburn knows. But how exactly this is triggered was not known in detail until now. "In our study, we took a closer look at the processes involved," explains ImmunoSensation2 member Prof. Dr. Florian Schmidt, who heads a research group at the Institute of Innate Immunity at the University Hospital Bonn. "We have now been able to show that a known cellular stress signaling pathway can trigger these inflammatory responses"

UV stress triggers signal chain

Ultraviolet radiation can cause damage to ribosomal RNAs. This induces the ribotoxic stress response which ultimately leads to the activation of p38 mitogen-activated protein kinases (MAPKs). Also, the radiation induces NLRP1-mediated inflammation. Until now, it was unclear how this exactly happens. Hence, the researchers around Florian Schmidt analyzed the signaling cascades upstream of NLRP1. "Our research shows that p38 molecularly modifies NLRP1, a critical switch for inflammation in the skin, and thus activates it in a novel way. This initiates the assembly of inflammasomes from many molecular building blocks." explains Schmidt, who is also a member of the Transdisciplinary Research Area (TRA) "Life and Health" at the University of Bonn. p38 was shown to directly phosphorylate NLRP1, inducing a subsequent ubiquitination, degradation and nucleation of inflammasomes by the resulting NLRP1 degradation product.

Viruses also activate p38

Interestingly, p38 and NLRP1 are not only activated by UV-radiation. "We were able to show that mosquito-borne viruses can activate NLRP1 through p38 as well," emphasizes Lea-Marie Jenster, a PhD student in the Schmidt lab and the lead author of this study. "These include, for instance, chikungunya virus, which is a major problem in parts of Africa and Asia and could also reach Germany in the wake of climate change." In contrast, activation of NLRP1 by other known mechanisms, as nanobody-mediated ubiquitination, viral proteases, or blocking of the NLRP1 inhibiting dipeptidyl peptidase 9 (DPP9) was found independent of p38 activity.

Taken together, p38 activation is identified as a unifying signaling hub that integrates a variety of cellular stress signals relevant to the skin and thus controls NLRP1 inflammasome activation in karyocytes. "However, not every incoming call for help immediately triggers the assembly of inflammasomes - this only happens when the number and intensity of alerts exceed a certain threshold" Schmidt explains. Sometimes, however, inflammasome formation is controlled not strictly enough - as in the case of sunburn or even some autoimmune diseases. Perhaps p38 opens up a new possibilities to specifically suppress such exuberant immune reactions in the skin in the future.


Participating institutions
In addition to the University Hospital of Bonn and the University of Bonn, the University of Melbourne (Australia) and Boston Children's Hospital (USA) were involved in the study.


Funding

The work was funded by the German Research Foundation (DFG) and the Klaus Tschira Boost Fund.


Publication

Lea-Marie Jenster, Karl-Elmar Lange, Sabine Normann, Anja vom Hemdt, Jennifer D. Wuerth, Lisa D.J. Schiffelers, Yonas M. Tesfamariam, Florian N. Gohr, Laura Klein, Ines H. Kaltheuner, Dorothee J. Lapp, Jacob Mayer, Jonas Moecking, Hidde L. Ploegh, Eicke Latz, Matthias Geyer, Beate M. Kümmerer, Florian I. Schmidt: P38 kinases mediate NLRP1 inflammasome activation after ribotoxic stress response and virus infection; Journal of Experimental Medicine; https://doi.org/10.1084/jem.20220837


Contact

Prof. Florian I. Schmidt

Institute of Innate Immunity

University of Bonn

Email: fschmidt@uni-bonn.de

Tel. Office: +49-228/287-51124

Tel. Lab: +49-228/287-54708

mobile: +49-176/70021810

Related news

Neurons - generated through the differentiation of induced neural stem cells (iNSCs) derived from blood.

News categories: Publication

Researchers Transform Old Blood Cells into Young Brain Cells

—Researchers from the University Hospital of Bonn and the University of Bonn have succeeded in dramatically rejuvenating human cells in a test tube. To do so, they directly reprogrammed red blood cell precursors into stem cells from which neurons can be derived. During this process, the molecular clocks that indicate a cell’s age were reset. For example, blood cells from an 80-year-old were transformed into stem cells with a molecular age of less than 20 years. The results have been published in the journal Aging Cell.
View entry
Dr. Robert Hüneburg, Dr. Anne-Sophie Layritz, and Nicola Reents (from left) - conducted a survey and found that fewer than one in ten people with Lynch syndrome take Acetylsalicylic acid for cancer prevention – despite a high level of openness to new preventive approaches.

News categories: Publication

Aspirin Rarely Used for Colorectal Cancer Prevention

—According to international studies, taking Acetylsalicylic acid daily can protect people with Lynch syndrome from developing colorectal cancer – even at low doses. Researchers from the University Hospital Bonn (UKB), the University of Bonn, and the Center for Integrated Oncology (CIO) Bonn, in collaboration with the self-help organization SemiColon, have now found that these scientific findings have so far been insufficiently incorporated into clinical practice. The results of the LYNX study have now been published as a letter in the journal The Lancet Gastroenterology & Hepatology.
View entry
Smartphone-based retinal imaging in clinical practice in India: - The image was taken during a collaborative project between University Hospital Bonn (UKB) and Sankara Eye Foundation India on smartphone-based telemedical screening for diabetic retinopathy.

News categories: Publication

Smartphones as Retinal Cameras: New Opportunities for Global Eye Care

—Smartphones could play an important role in the early detection of eye diseases, including in settings where specialized ophthalmic infrastructure is limited. An international team of experts led by the UKB and the University of Bonn has comprehensively reviewed the current global landscape of smartphone-based fundus imaging. The researchers highlight the technical and clinical possibilities that already exist today, identify the limitations of these methods, and outline the conditions that must be met so that smartphone-based retinal imaging can be more widely integrated into screening.
View entry

Back to the news overview